title: Genetic analysis of the calcineurin pathway identifies members of the EGR gene family, specifically EGR3, as potential susceptibility candidates in schizophrenia.
abstract: The calcineurin cascade is central to neuronal signal transduction, and genes in this network are intriguing candidate schizophrenia susceptibility genes. To replicate and extend our previously reported association between the PPP3CC gene, encoding the calcineurin catalytic gamma-subunit, and schizophrenia, we examined 84 SNPs from 14 calcineurin-related candidate genes for genetic association by using 124 Japanese schizophrenic pedigrees. Four of these genes (PPP3CC, EGR2, EGR3, and EGR4) showed nominally significant association with schizophrenia. In a postmortem brain study, EGR1, EGR2, and EGR3 transcripts were shown to be down-regulated in the prefrontal cortex of schizophrenic, but not bipolar, patients. These findings raise a potentially important role for EGR genes in schizophrenia pathogenesis. Because EGR3 is an attractive candidate gene based on its chromosomal location close to PPP3CC within 8p21.3 and its functional link to dopamine, glutamate, and neuregulin signaling, we extended our analysis by resequencing the entire EGR3 genomic interval and detected 15 SNPs. One of these, IVS1 + 607A-->G SNP, displayed the strongest evidence for disease association, which was confirmed in 1,140 independent case-control samples. An in vitro promoter assay detected a possible expression-regulatory effect of this SNP. These findings support the previous genetic association of altered calcineurin signaling with schizophrenia pathogenesis and identify EGR3 as a compelling susceptibility gene.
authors.affiliation: Laboratories for Molecular Psychiatry, RIKEN Brain Science Institute, Saitama 351-0198, Japan.
authors.forename: Kazuo
authors.initials: K
authors.lastname: Yamada
authors.forename: David J
authors.initials: DJ
authors.lastname: Gerber
authors.forename: Yoshimi
authors.initials: Y
authors.lastname: Iwayama
authors.forename: Tetsuo
authors.initials: T
authors.lastname: Ohnishi
authors.forename: Hisako
authors.initials: H
authors.lastname: Ohba
authors.forename: Tomoko
authors.initials: T
authors.lastname: Toyota
authors.forename: Jun
authors.initials: J
authors.lastname: Aruga
authors.forename: Yoshio
authors.initials: Y
authors.lastname: Minabe
authors.forename: Susumu
authors.initials: S
authors.lastname: Tonegawa
authors.forename: Takeo
authors.initials: T
authors.lastname: Yoshikawa
mesh_terms: D000328:Adult; D001921:Brain / Q000378:metabolism; D019703:Calcineurin / Q000235:genetics* / Q000378:metabolism; D016022:Case-Control Studies; D051776:Early Growth Response Protein 3 / Q000235:genetics* / Q000378:metabolism; D005260:Female; D005786:Gene Expression Regulation; D020022:Genetic Predisposition to Disease; D005820:Genetic Testing; D006801:Humans; D015810:Linkage Disequilibrium / Q000235:genetics; D008297:Male; D008875:Middle Aged; D005810:Multigene Family / Q000235:genetics*; D010375:Pedigree; D020641:Polymorphism, Single Nucleotide / Q000235:genetics; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D012559:Schizophrenia / Q000235:genetics*
chemical_list: D012333:RNA, Messenger; D051776:Early Growth Response Protein 3; D019703:Calcineurin